The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case–control study
Edoardo Spinazzola, Diego Quattrone, Victoria Rodriguez, Giulia Trotta, Luis Alameda, Giada Tripoli, Charlotte Gayer‐Anderson, Tom P. Freeman, E. Johnson, Hannah E. Jongsma, Simona A. Stilo, Caterina la Cascia, L. Ferraro, Daniele la Barbera, Antonio Lasalvia, Sarah Tosato, Ilaria Tarricone, G. D'Andrea, M. Galatolo, Andrea Tortelli, I. Tagliabue, M. Turco, M. Pompili, J. Selten, Lieuwe de Haan, Paulo Rossi Menezes, C. D. del Ben, J. Santos, Manuel Arrojo, Julio Bobes, Julio Sanjuán, Miquel Bernardo, Celso Arango, James B. Kirkbride, P. Jones, Michael O'Donovan, Bart P. F. Rutten, Jim van Os, C. Morgan, Pak C. Sham, Isabelle Austin-Zimmerman, Zhi-Kun Li, Evangelos Vassos, Robin Murray, Marta Di Forti
Psychological Medicine May 2, 2023 DOI: 10.1017/s0033291723001071 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case-control study Peer reviewed |
|---|---|
| Sample size | 1,125 |
| Population | 558 first-episode psychosis patients and 567 population controls who had used cannabis and reported their reasons for first using cannabis, drawn from 11 sites of the EU-GEI study |
| Topics | Cannabis |
| Key findings | Both first-episode psychosis patients and controls usually began using cannabis with friends, but more patients than controls began 'to feel better' (20.1% vs 5.8%). Reporting 'to feel better' as the reason for first use was associated with being a patient (OR 1.74) and, in a path model, with heavy cannabis use and psychosis case-control status, while 'with friends' was associated with being a control (OR 0.56). |
Abstract
Abstract Background While cannabis use is a well-established risk factor for psychosis, little is known about any association between reasons for first using cannabis (RFUC) and later patterns of use and risk of psychosis.
Methods: We used data from 11 sites of the multicentre European Gene-Environment Interaction (EU-GEI) case–control study. 558 first-episode psychosis patients (FEPp) and 567 population controls who had used cannabis and reported their RFUC. We ran logistic regressions to examine whether RFUC were associated with first-episode psychosis (FEP) case–control status. Path analysis then examined the relationship between RFUC, subsequent patterns of cannabis use, and case–control status.
Results: Controls (86.1%) and FEPp (75.63%) were most likely to report ‘because of friends’ as their most common RFUC. However, 20.1% of FEPp compared to 5.8% of controls reported: ‘to feel better’ as their RFUC (χ2 = 50.97; p < 0.001). RFUC ‘to feel better’ was associated with being a FEPp (OR 1.74; 95% CI 1.03–2.95) while RFUC ‘with friends’ was associated with being a control (OR 0.56; 95% CI 0.37–0.83). The path model indicated an association between RFUC ‘to feel better’ with heavy cannabis use and with FEPp-control status.
Conclusions: Both FEPp and controls usually started using cannabis with their friends, but more patients than controls had begun to use ‘to feel better’. People who reported their reason for first using cannabis to ‘feel better’ were more likely to progress to heavy use and develop a psychotic disorder than those reporting ‘because of friends’.
Comparable studies
Other observational and cohort studies on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| High-potency cannabis and the risk of psychosis People with first episode of psychosis and healthy controls from the local population | 2009 | Case-control study | n = 454 |
| Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Rural aboriginal population | 2013 | Observational study | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Individuals from the general population in Germany aged 14-24 at baseline | 2011 | Observational cohort | n = 1,923 |
| Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases Patients treated for cannabis-induced psychotic symptoms in Denmark between 1994 and... | 2005 | Observational cohort | n = 535 |
Citations in the library
Cites 11
- High-potency cannabis and the risk of psychosis The British Journal of Psychiatry November 30, 2009
- Gone to Pot – A Review of the Association between Cannabis and Psychosis Frontiers in Psychiatry May 22, 2014
- Subjective Effects of Cannabis Before the First Psychotic Episode Australian & New Zealand Journal of Psychiatry December 1, 2009
- Premorbid Adjustment and IQ in Patients With First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship With Cannabis Use Schizophrenia Bulletin July 2, 2019
- Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis Psychological Medicine September 12, 2022
and 6 more in the library